Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermatitis (AD).
Sponsor: Eli Lilly and Company
Check if you qualify for this atopic dermatitis clinical trial in Phoenix, AZ
If you're searching for atopic dermatitis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.